Related Experiment Video
Updated: Aug 29, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Aberrant transcription factors in the cancers of the pancreas
Md Hafiz Uddin1, Md Najeeb Al-Hallak1, Philip A Philip2
1Department of Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Abstract:
Transcription factors (TFs) are essential for proper activation of gene during the process of organogenesis, differentiation, lineage specificity. Reactivation or dysregulation of TFs regulatory networks could lead to deformation of organs, diseases including various malignancies. Currently, understanding the mechanism of oncogenesis became a necessity for the development of targeted therapeutic strategy for different cancer types. It is evident that many TFs go awry in cancers of the pancreas such as pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine neoplasms (PanNENs). These mutated or dysregulated TFs abnormally controls various signaling pathways in PDAC and PanNENs including RTK, PI3K-PTEN-AKT-mTOR, JNK, TGF-β/SMAD, WNT/β-catenin, SHH, NOTCH and VEGF which in turn regulate different hallmarks of cancer. Aberrant regulation of such pathways have been linked to the initiation, progression, metastasis, and resistance in pancreatic cancer. As of today, a number of TFs has been identified as crucial regulators of pancreatic cancer and a handful of them shown to have potential as therapeutic targets in pre-clinical and clinical settings. In this review, we have summarized the current knowledge on the role and therapeutic usefulness of TFs in PDAC and PanNENs.
Insights
Transcription factors (TFs) are crucial in gene activation for development. Dysregulated TFs drive pancreatic cancers like PDAC and PanNENs, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Transcription factors (TFs) regulate gene expression essential for organogenesis and cell differentiation.
- Dysregulation of TF networks can lead to developmental abnormalities and diseases, including malignancies.
- Understanding oncogenesis mechanisms is vital for developing targeted cancer therapies.
Purpose of the Study:
- To review the role of transcription factors in pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine neoplasms (PanNENs).
- To summarize the therapeutic potential of identified TFs as drug targets in pancreatic cancers.
Main Methods:
- Literature review of current knowledge on TFs in pancreatic cancer.
- Analysis of TF involvement in key signaling pathways implicated in PDAC and PanNENs.
- Examination of pre-clinical and clinical data on TF-targeted therapies.
Main Results:
- Numerous TFs are dysregulated in PDAC and PanNENs, impacting critical cancer hallmarks.
- Mutated or aberrant TFs abnormally control signaling pathways such as RTK, PI3K-AKT-mTOR, JNK, TGF-β, WNT, SHH, NOTCH, and VEGF.
- Several TFs have emerged as significant regulators and potential therapeutic targets in pancreatic cancer.
Conclusions:
- Transcription factors play a critical role in the initiation, progression, metastasis, and therapeutic resistance of pancreatic cancers.
- Targeting specific TFs presents a promising strategy for novel therapeutic interventions in PDAC and PanNENs.
More Related Videos
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
Transcription Factors
General Transcription Factors
Master Transcription Regulators
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Induced Pluripotent Stem Cells
Somatic...